Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis
Jin Zhao(Shenyang Pharmaceutical University), Jun Yin(Shenyang Pharmaceutical University), Kun Yang(Fujian Medical University), Zhong‐Ze Fang(Tianjin Medical University), Yongzhe Liu(The Military General Hospital of Beijing PLA), Yun‐Feng Cao(Jinzhou Medical University), Frank J. Gonzalez(National Institutes of Health), Jingjing Wu(Army Medical University), Zhi‐Tu Zhu(First Affiliated Hospital of Liaoning Medical University), Tao Sun, Hongzhi Sun(Jinzhou Medical University)
Cited by 23
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
|Journal of the American Society of Nephrology|2017|222